Intensity-modulated radiation therapy for intermediate-risk prostate cancer: does ADT still have an impact in the dose-escalated external beam radiation therapy era?

CONCLUSION: ADT may not always be effective in all Japanese IR-PCA patients treated with DE-EBRT, but it can improve biochemical control in patients with GS 4 + 3.PMID:36946312 | DOI:10.1093/jjco/hyad019

Source: Clinical Prostate Cancer - March 22, 2023 Category: Cancer & Oncology Authors: Takashi Soyano Takuyo Kozuka Kenichi Kashihara Yu Murakami Junji Yonese Kazuma Sasamura Nana Shimoyachi Tairo Kashihara Yasuo Yoshioka Masahiko Oguchi Source Type: research